Publication Name	World Journal of Dermatology
Manuscript ID	80847
Country	Türkiye

Received	2022-10-14 10:26
Peer-Review Started	2022-10-14 10:29
To Make the First Decision
Return for Revision	2022-11-04 08:26
Revised	2022-11-10 15:51
Second Decision	2022-12-20 08:13
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2022-12-21 08:04
Articles in Press	2022-12-21 08:04
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-01-13 02:39
Publish the Manuscript Online	2023-01-16 02:24

ISSN	2218-6190 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Dermatology
Manuscript Type	Case Report
Article Title	Generalized prurigo nodularis with dramatic response to dupilumab treatment: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Cagdas Boyvadoglu and Huseyin Serhat Inalöz
Funding Agency and Grant Number
Corresponding Author	Huseyin Serhat Inalöz, Doctor, Assistant Professor, Dermatology, University of Gaziantep Faculty of Medicine, Gaziantep Üniversitesi Şahinbey Araştırma ve Uygulama Hastanesi Üniversite Bulvar P.K. 27310, Şehitkamil / Gaziantep, Gaziantep 27270, Türkiye. serhatinaloz@hotmail.com
Key Words	Dupilumab; Prurigo nodularis; Pruritus; Immunoglobulin E; Atopic dermatitis; Case report
Core Tip	Prurigo nodularis (PN) is a difficult disease to treat and causes frustration to both the patient and the treating doctor. Treatment of PN is based on clinical experience rather than controlled trials. PN is a disease that negatively affects the quality of life of patients due to severe itching. Patients often receive limited benefit from first-line treatments and require systemic therapy. Dupilumab treatment stands out as an effective and safe systemic treatment agent among existing systemic treatments. In this case, we show how effective and well tolerated treatment with dupilumab is in the treatment of recalcitrant PN.
Publish Date	2023-01-16 02:24
Citation	Boyvadoglu C, Inalöz HS. Generalized prurigo nodularis with dramatic response to dupilumab treatment: A case report. World J Dermatol 2023; 11(1): 1-6
URL	https://www.wjgnet.com/2218-6190/full/v11/i1/1.htm
DOI	https://dx.doi.org/10.5314/wjd.v11.i1.1

Full Article (PDF)	WJD-11-1.pdf
Full Article (Word)	WJD-11-1.docx
CARE Checklist–2016	80847-CARE-Checklist–2016-revision.pdf
Manuscript File	80847_Auto_Edited-JLW.docx
Answering Reviewers	80847-Answering reviewers.pdf
Audio Core Tip	80847-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	80847-Conflict-of-interest statement.pdf
Copyright License Agreement	80847-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s)	80847-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	80847-Language certificate.pdf
Peer-review Report	80847-Peer-review(s).pdf
Scientific Misconduct Check	80847-Bing-Liu GL-2.png
Scientific Editor Work List	80847-Scientific editor work list.pdf
CrossCheck Report	80847-CrossCheck report.pdf